Use of a Traumatic Brain Injury (TBI) Screen in a Veteran Mental Health Population
NCT ID: NCT01118182
Last Updated: 2018-08-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1810 participants
OBSERVATIONAL
2009-06-30
2016-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identifying the Needs of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) Veterans and Their Families: TBI and Co-Occurring Behavioral Health Issues
NCT01502852
Telehealth-Education-Based Program for Military Caregivers of Injured Service Members With Head Injuries
NCT02215187
Evaluation of Military Service and Family Members for Post Concussive and Posttraumatic Stress Symptoms
NCT03191357
Study of PTSD in Military Veterans Who Have Suffered Traumatic Brain Injuries
NCT02003352
Improving Cognitive Rehabilitation Outcomes
NCT07055633
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Primary Hypotheses:
Hypothesis 1a: The sensitivity and specificity of the TBI-4 will be significantly greater than 0.75 and 0.80, respectively.
Hypothesis 1b: The sensitivity and specificity of the TBI-4 with the addition of detailed information elicited by these questions (i.e., free text information entered by the clinician who administered the TBI-4) will be significantly greater than 0.75 and 0.80, respectively.
Secondary Hypotheses:
Hypothesis 1c: The specificity of the TBI-4 with the addition of detailed information elicited by these questions (i.e., free text information entered by the clinician who administered the TBI-4) will be significantly greater than that of the four questions alone.
Hypothesis 2: A significant difference in psychiatric outcomes (psychiatric hospitalizations, suicidal ideation, suicide attempts and completions, and mental health-related contacts) will be identified in those with a history of TBI versus those without a history of TBI as determined, first, by the TBI-4 and, second, by the OSU TBI-ID.
Hypothesis 3: The prevalence of Traumatic Brain Injury- Loss of Consciousness (TBI-LOC) in this population will be similar to that identified by Walker et al1 (31.7% of individuals will report 1 or more TBI-LOC).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Traumatic Brain Injury (TBI)
Veterans with a positive history of TBI
No interventions assigned to this group
No Traumatic Brain Injury (TBI)
Veterans with a negative history of TBI
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Veteran must have had a mental health intake no earlier than January of 2007.
Exclusion Criteria
* No Mental Health Intake note in the medical record.
* Presence of a Mental Health Intake note in the computer which does not contain the TBI-4
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Colorado Traumatic Brain Injury Trust Fund
OTHER
Ohio State University
OTHER
University of Colorado, Denver
OTHER
VA Eastern Colorado Health Care System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lisa Brenner
Director, VA VISN 19 Mental Illness Research Education and Clinical Center (MIRECC)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lisa A Brenner, PhD
Role: PRINCIPAL_INVESTIGATOR
VISN 19 MIRECC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Denver VA Medical Center
Denver, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Rocky Mountain MIRECC website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMIRB08-0001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.